Read + Share
Amedeo Smart
Independent Medical Education
Garassino MC, Mazieres J, Reck M, Chouaid C, et al. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial. J Thorac Oncol 2022;17:1415-1427.PMID: 35961520
Email
LinkedIn
Facebook
Twitter
Privacy Policy